Skip to main content

Pulmonx Corp

For the period ended Sep 30, 2024. Filed Nov 1, 2024.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2024 · Filed Nov 1, 2024

LUNG$2.80+9.4%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Condensed Consolidated Balance Sheets

(in thousands, except share and per share amounts)

September 30, 2024December 31, 2023
Assets
Current assets
Cash and cash equivalents$63,312$83,547
Restricted cash258237
Short-term marketable securities44,46733,555
Accounts receivable, net11,67012,105
Inventory16,95916,743
Prepaid expenses and other current assets4,2634,235
Total current assets140,929150,422
Long-term marketable securities—14,390
Long-term inventory2,2662,580
Property and equipment, net2,9834,028
Goodwill2,3332,333
Intangible assets, net—31
Right of use assets18,2363,406
Other long-term assets654591
Total assets$167,401$177,781
Liabilities and Stockholders’ Equity
Current liabilities
Accounts payable$4,576$1,497
Accrued liabilities12,77916,234
Income taxes payable7493
Deferred revenue109104
Short-term debt992,155
Current lease liabilities6633,074
Total current liabilities18,30023,157
Deferred tax liability129114
Long-term lease liabilities17,9101,106
Long-term debt37,13735,089
Total liabilities73,47659,466
Commitments and contingencies (Note 8)
Stockholders’ equity
Preferred stock, $0.001 par value, 10,000,000 shares authorized; no shares issued and outstanding as of September 30, 2024 and December 31, 2023——
Common stock, $0.001 par value, 200,000,000 shares authorized as of September 30, 2024 and December 31, 2023; 39,487,879 shares issued and outstanding as of September 30, 2024 and 38,516,383 shares issued and outstanding as of December 31, 20233939
Additional paid-in capital545,732526,797
Accumulated other comprehensive income2,5342,640
Accumulated deficit(454,380)(411,161)
Total stockholders’ equity93,925118,315
Total liabilities and stockholders’ equity$167,401$177,781
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.